awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26851443-E6635BFA-C3F4-4D66-8379-0D4411E9847C
Q26851443-E6635BFA-C3F4-4D66-8379-0D4411E9847C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851443-E6635BFA-C3F4-4D66-8379-0D4411E9847C
The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management
P2860
Q26851443-E6635BFA-C3F4-4D66-8379-0D4411E9847C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851443-E6635BFA-C3F4-4D66-8379-0D4411E9847C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbdb74a26a6a0d68a07fe3f4c73ccb013d1f9683
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.